Colonic Neoplasms Clinical Trials

11 recruiting

Colonic Neoplasms Trials at a Glance

13 actively recruiting trials for colonic neoplasms are listed on ClinicalTrialsFinder across 6 cities in 29 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Toronto, Halifax, and Ann Arbor. Lead sponsors running colonic neoplasms studies include AdventHealth Translational Research Institute, Azienda USL Reggio Emilia - IRCCS, and Amphia Hospital.

Browse colonic neoplasms trials by phase

Treatments under study

About Colonic Neoplasms Clinical Trials

Looking for clinical trials for Colonic Neoplasms? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Colonic Neoplasms trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Colonic Neoplasms clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Phase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more
National Cancer Institute (NCI)100 enrolled1 locationNCT06885697
Recruiting
Phase 3

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Colonic NeoplasmsNeoplasms, Colon
GlaxoSmithKline892 enrolled266 locationsNCT05855200
Recruiting
Not Applicable

Strategies for Optimizing a Mailed FIT Program in Appalachia

Colonic Neoplasms
Ohio State University Comprehensive Cancer Center500 enrolled1 locationNCT07173985
Recruiting
Not Applicable

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

Colonic Neoplasms
AdventHealth Translational Research Institute219 enrolled3 locationsNCT05773144
Recruiting

Endoscopic Resection of Gastrointestinal Neoplasms

Esophageal NeoplasmsColonic NeoplasmsEndoscopic Mucosal Resection+3 more
Azienda USL Reggio Emilia - IRCCS2,000 enrolled1 locationNCT04780256
Recruiting
Not Applicable

Effects of Aerobic Exercise on Skeletal Muscle Remodeling in Colorectal Cancer

Rectal NeoplasmsColonic Neoplasms
AdventHealth Translational Research Institute70 enrolled1 locationNCT05789433
Recruiting

Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas

Colonic Neoplasms
University of Michigan Rogel Cancer Center1,200 enrolled13 locationsNCT00843375
Recruiting
Phase 3

CompariSon Between the EuroPeAn and Japanese pathologiCal InvEstigation for Colon Cancer (SPACE)

Colonic Neoplasms
Russian Society of Colorectal Surgeons430 enrolled1 locationNCT06119867
Recruiting
Not Applicable

IBD Neoplasia Surveillance RCT

Inflammatory Bowel DiseasesColonic NeoplasmsDysplasia
Ottawa Hospital Research Institute1,952 enrolled11 locationsNCT05809999
Recruiting

Obstructive Colon Cancer, a Bridge to Surgery in Right Sided Obstructive Colon Cancer

Colonic Neoplasms Malignant
Amphia Hospital110 enrolled1 locationNCT06338332
Recruiting
Not Applicable

Local Cecal Cancer - Optimization of Surgical Treatment

Colonic Neoplasms MalignantCecal Neoplasms
Moscow Clinical Scientific Center200 enrolled1 locationNCT06121089
Recruiting
Not Applicable

Artificial Intelligence to Implement Cost-saving Strategies for Colonoscopy Screening Based on in Vivo Prediction of Polyp Histology

Colonic Neoplasms
Istituto Clinico Humanitas1,800 enrolled2 locationsNCT06041945
Recruiting
Phase 1Phase 2

The Efficacy of JS001 Combined With Chemotherapy in Patients With Locally Advanced Colon Cancer

Chemotherapy EffectColonic Neoplasms
Xiangya Hospital of Central South University40 enrolled1 locationNCT03985891